Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07078968 · ClinicalTrials.gov registry record
A Real World Data Collection OF Human Amniotic Membrane(s) ON Diabetic Foot Ulcers, Venous LEG Ulcers, Pressure Ulcers AND Post Operative Wounds
A clinical trial of Diabetic Foot Ulcer (DFU) and Venous Leg Ulcer (VLU), sponsored by BioLab Holdings.
- Active
- Registry status
- 500
- Enrollment target
- 4
- Study locations
NCT07078968: Active study of Diabetic Foot Ulcer (DFU) and Venous Leg Ulcer (VLU), sponsored by BioLab Holdings.
NCT07078968 is a study of Diabetic Foot Ulcer (DFU) and Venous Leg Ulcer (VLU) that is active but no longer recruiting, run by BioLab Holdings. The registered enrollment target is 500 participants, roughly in line with the 480-participant average among 13 other Diabetic Foot Ulcer (DFU) trials with a reported enrollment target. The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07078968, a study of Diabetic Foot Ulcer (DFU) and Venous Leg Ulcer (VLU), is active but no longer recruiting, sponsored by BioLab Holdings.
- ACTIVE NOT RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 4
- Study locations
Study Summary
This study is designed to evaluate the effectiveness of Tri-Membrane Wrap™, Membrane Wrap™ and Membrane Wrap-Hydro™ compared to the effectiveness of Standard of Care alone though a retrospective data collection.
Primary Outcome
Wound closure is defined as: Full epithelialization of the wound with the absence of drainage. Epithelialization is defined as a layer of epithelium visible on the wound surface
Conditions Studied
Interventions
- OTHER Standard of Care
- DEVICE Membrane Wrap™
- DEVICE Tri-Membrane Wrap™
- DEVICE Membrane Wrap-Hydro™
Study Locations (4)
Texas
- Houston Foot and Ankle Care - Houston
- Houston Foot Dr - Houston
Arizona
- Athena Specialty Group - Phoenix
New Jersey
- Revive Advanced Wound Care - Toms River
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2025-04-23 |
| Est. Completion | 2025-10 |
What the registry record for NCT07078968 still lists
NCT07078968 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 480-participant average among 13 other Diabetic Foot Ulcer (DFU) trials with a reported enrollment target.
The record links to 3 conditions, with Diabetic Foot Ulcer (DFU) appearing as the primary indexed condition, and to 4 interventions - of which Standard of Care is the first listed.
NCT07078968 reports a single indexed study location in Texas, Arizona, New Jersey.
Frequently Asked Questions
What is clinical trial NCT07078968 about?
NCT07078968 is a clinical study titled "A Real World Data Collection OF Human Amniotic Membrane(s) ON Diabetic Foot Ulcers, Venous LEG Ulcers, Pressure Ulcers AND Post Operative Wounds". This study is designed to evaluate the effectiveness of Tri-Membrane Wrap™, Membrane Wrap™ and Membrane Wrap-Hydro™ compared to the effectiveness of Standard of Care alone though a retrospective data collection.
What is the current status of trial NCT07078968?
This trial is currently active not recruiting. The enrollment target is 500 participants. The study started on 2025-04-23. Estimated completion is 2025-10.
What conditions does trial NCT07078968 study?
This clinical trial studies the following conditions: Diabetic Foot Ulcer (DFU), Venous Leg Ulcer (VLU), Pressure Ulcer (PU).
What interventions are being tested in trial NCT07078968?
The interventions under investigation include: Standard of Care (OTHER), Membrane Wrap™ (DEVICE), Tri-Membrane Wrap™ (DEVICE), Membrane Wrap-Hydro™ (DEVICE).
Who is sponsoring clinical trial NCT07078968?
This trial is sponsored by BioLab Holdings, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07078968 being conducted?
This trial has 4 study locations across Arizona, New Jersey, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Foot Ulcer (DFU)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07078968's enrollment target sits among peer trials
500 3rd of 13 higher than 11 of 13 other Diabetic Foot Ulcer (DFU) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetic Foot Ulcer (DFU) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Randomized Evaluation of Nonhealing Diabetic Foot Ulcers With Exclusive Wound Therapy
RECRUITING · Phase 4
-
A Non-Randomized Open Label Clinical Trial Evaluating DermaBind TL
RECRUITING · Phase 4
-
Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers
RECRUITING · NA
-
CARE-D-FOOT-Nav Pilot
RECRUITING · NA
-
A Prospective Clinical Study to Evaluate the Effectiveness and Safety of Xcell Amnio MatrixTM (XAM) in the Management of Chronic Non-healing DFUs
RECRUITING · NA
-
CAMP RWE Trial: Amnion Grafts for Healing Hard-to-Heal Ulcers in RW Populations
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI